Search

Your search keyword '"Dmitrovsky, Ethan"' showing total 675 results
Start Over Author "Dmitrovsky, Ethan"
675 results on '"Dmitrovsky, Ethan"'

1. A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

Author

Wei, Cheng-Hsin, Huang, Lu, Kreh, Blair, Liu, Xiuxia, Tyutyunyk-Massey, Liliya, Kawakami, Masanori, Chen, Zibo, Shi, Mi, Kozlov, Serguei, Chan, King C., Andresson, Thorkell, Carrington, Mary, Vuligonda, Vidyasagar, Sanders, Martin E., Horowitz, Amir, Hwu, Patrick, Peng, Weiyi, Dmitrovsky, Ethan, and Liu, Xi

Published
2023
Full Text
View/download PDF

2. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer

Author

Sepesi, Boris, Gold, Kathryn A, Correa, Arlene M, Heymach, John V, Vaporciyan, Ara A, Roszik, Jason, Dmitrovsky, Ethan, and Liu, Xi

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Prevention, Lung, Patient Safety, Cancer, Lung Cancer, Clinical Research, Obesity, Adolescent, Adult, Aged, Aged, 80 and over, Body Mass Index, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Middle Aged, Survival Analysis, Young Adult, BMI, Lung cancer, Overall survival, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis
Abstract

BackgroundPopulation studies suggest that high body mass index (BMI) correlates with a reduced risk for death from lung cancer. The aim of our study was to evaluate definitively the influence of BMI on long-term overall survival (OS) in surgical patients with NSCLC.MethodsThe study population consisted of 1935 patients who underwent surgical resection for lung cancer at M. D. Anderson Cancer Center (2000-2014). Study variables included both patient- and treatment-related characteristics. Univariate and multivariate Cox regression analyses were performed to identify variables associated with OS.ResultsOn univariate analysis, significant predictors of improved survival were higher BMI, pathologic tumor stage (stage I versus stage II, III, or IV), type of surgical procedure (lobectomy/pneumonectomy versus wedge resection/segmentectomy), younger age, female sex, and adenocarcinoma histologic subtype (versus squamous) (all p < 0.05). Morbidly obese patients (BMI ≥ 35) demonstrated a trend toward better outcomes than those classified as obese (BMI ≥30 and

Published
2017

3. Retinoids and rexinoids in cancer prevention: from laboratory to clinic

Author

Uray, Iván P, Dmitrovsky, Ethan, and Brown, Powel H

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Hematology, Prevention, Rare Diseases, Nutrition, Cancer, Animals, Anticarcinogenic Agents, Chemoprevention, Humans, Neoplasms, Nervous System Diseases, Pulmonary Disease, Chronic Obstructive, Receptors, Retinoic Acid, Retinoid X Receptors, Retinoids, Signal Transduction, Skin Diseases, Cancer prevention, Combination, Medical use, Retinoid, Rexinoid, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

Early in the age of modern medicine the consequences of vitamin A deficiency drew attention to the fundamental link between retinoid-dependent homeostatic regulation and malignant hyperproliferative diseases. The term "retinoid" includes a handful of endogenous and a large group of synthetic derivatives of vitamin A. These multifunctional lipid-soluble compounds directly regulate target genes of specific biological functions and critical signaling pathways to orchestrate complex functions from vision to development, metabolism, and inflammation. Many of the retinoid activities on the cellular level have been well characterized and translated to the regulation of processes like differentiation and cell death, which play critical roles in the outcome of malignant transformation of tissues. In fact, retinoid-based differentiation therapy of acute promyelocytic leukemia was one of the first successful examples of molecularly targeted treatment strategies. The selectivity, high receptor binding affinity and the ability of retinoids to directly modulate gene expression programs present a distinct pharmacological opportunity for cancer treatment and prevention. However, to fully exploit their potential, the adverse effects of retinoids must be averted. In this review we provide an overview of the biology of retinoid (activated by nuclear retinoic acid receptors [RARs]) and rexinoid (engaged by nuclear retinoid X receptors [RXRs]) action concluded from a long line of preclinical studies, in relation to normal and transformed states of cells. We will also discuss the past and current uses of retinoids in the treatment of malignancies, the potential of rexinoids in the cancer prevention setting, both as single agents and in combinations.

Published
2016

4. REPLY TO OEGEMA ET AL. : CFI-400945 and Polo-like kinase 4 inhibition

Author

Kawakami, Masanori, Mustachio, Lisa Maria, Zheng, Lin, Chen, Yulong, Rodriguez-Canales, Jaime, Mino, Barbara, Kurie, Jonathan M., Roszik, Jason, Villalobos, Pamela Andrea, Thu, Kelsie L., Silvester, Jennifer, Cescon, David W., Wistuba, Ignacio I., Mak, Tak W., Liu, Xi, and Dmitrovsky, Ethan

Published
2018

7. Retinoids

Author

Dmitrovsky, Ethan, Spinella, Michael, and Marshall, John L., editor

Published
2017
Full Text
View/download PDF

11. Abstract 1836: Combining a novel retinoic acid receptor-γ agonist with immune checkpoint blockade represses lung cancer growth in vivo

Author

Wei, Cheng-Hsin, primary, Huang, Lu, additional, Kreh, Blair, additional, Liu, Xiuxia, additional, Tyutyunyk-Massey, Liliya, additional, Chen, Zibo, additional, Shi, Mi, additional, Vuligonda, Vidyasagar, additional, Sanders, Martin, additional, Kozlov, Serguei, additional, Chan, King, additional, Horowitz, Amir, additional, Carrington, Mary, additional, Hwu, Patrick, additional, Peng, Weiyi, additional, Dmitrovsky, Ethan, additional, and Liu, Xi, additional

Published
2023
Full Text
View/download PDF

12. Supplementary table from A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers

Author

Kawakami, Masanori, primary, Mustachio, Lisa Maria, primary, Chen, Yulong, primary, Chen, Zibo, primary, Liu, Xiuxia, primary, Wei, Cheng-Hsin, primary, Roszik, Jason, primary, Kittai, Adam S., primary, Danilov, Alexey V., primary, Zhang, Xiaoshan, primary, Fang, Bingliang, primary, Wang, Jing, primary, Heymach, John V., primary, Tyutyunyk-Massey, Liliya, primary, Freemantle, Sarah J., primary, Kurie, Jonathan M., primary, Liu, Xi, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

13. Data from Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models

Author

Dragnev, Konstantin H., primary, Ma, Tian, primary, Cyrus, Jobin, primary, Galimberti, Fabrizio, primary, Memoli, Vincent, primary, Busch, Alexander M., primary, Tsongalis, Gregory J., primary, Seltzer, Marc, primary, Johnstone, David, primary, Erkmen, Cherie P., primary, Nugent, William, primary, Rigas, James R., primary, Liu, Xi, primary, Freemantle, Sarah J., primary, Kurie, Jonathan M., primary, Waxman, Samuel, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table S1 from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Author

Chen, Limo, primary, Diao, Lixia, primary, Yang, Yongbin, primary, Yi, Xiaohui, primary, Rodriguez, B. Leticia, primary, Li, Yanli, primary, Villalobos, Pamela A., primary, Cascone, Tina, primary, Liu, Xi, primary, Tan, Lin, primary, Lorenzi, Philip L., primary, Huang, Anfei, primary, Zhao, Qiang, primary, Peng, Di, primary, Fradette, Jared J., primary, Peng, David H., primary, Ungewiss, Christin, primary, Roybal, Jonathon, primary, Tong, Pan, primary, Oba, Junna, primary, Skoulidis, Ferdinandos, primary, Peng, Weiyi, primary, Carter, Brett W., primary, Gay, Carl M., primary, Fan, Youhong, primary, Class, Caleb A., primary, Zhu, Jingfen, primary, Rodriguez-Canales, Jaime, primary, Kawakami, Masanori, primary, Byers, Lauren Averett, primary, Woodman, Scott E., primary, Papadimitrakopoulou, Vassiliki A., primary, Dmitrovsky, Ethan, primary, Wang, Jing, primary, Ullrich, Stephen E., primary, Wistuba, Ignacio I., primary, Heymach, John V., primary, Qin, F. Xiao-Feng, primary, and Gibbons, Don L., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figures 1-6 from The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth

Author

Liu, Xi, primary, Lu, Yun, primary, Chen, Zibo, primary, Liu, Xiuxia, primary, Hu, Weiguo, primary, Zheng, Lin, primary, Chen, Yulong, primary, Kurie, Jonathan M., primary, Shi, Mi, primary, Mustachio, Lisa Maria, primary, Adresson, Thorkell, primary, Fox, Stephen, primary, Roszik, Jason, primary, Kawakami, Masanori, primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

17. supplementary figure and legend from Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2

Author

Danilov, Alexey V., primary, Hu, Shanhu, primary, Orr, Bernardo, primary, Godek, Kristina, primary, Mustachio, Lisa Maria, primary, Sekula, David, primary, Liu, Xi, primary, Kawakami, Masanori, primary, Johnson, Faye M., primary, Compton, Duane A., primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

19. Data from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Author

Chen, Limo, primary, Diao, Lixia, primary, Yang, Yongbin, primary, Yi, Xiaohui, primary, Rodriguez, B. Leticia, primary, Li, Yanli, primary, Villalobos, Pamela A., primary, Cascone, Tina, primary, Liu, Xi, primary, Tan, Lin, primary, Lorenzi, Philip L., primary, Huang, Anfei, primary, Zhao, Qiang, primary, Peng, Di, primary, Fradette, Jared J., primary, Peng, David H., primary, Ungewiss, Christin, primary, Roybal, Jonathon, primary, Tong, Pan, primary, Oba, Junna, primary, Skoulidis, Ferdinandos, primary, Peng, Weiyi, primary, Carter, Brett W., primary, Gay, Carl M., primary, Fan, Youhong, primary, Class, Caleb A., primary, Zhu, Jingfen, primary, Rodriguez-Canales, Jaime, primary, Kawakami, Masanori, primary, Byers, Lauren Averett, primary, Woodman, Scott E., primary, Papadimitrakopoulou, Vassiliki A., primary, Dmitrovsky, Ethan, primary, Wang, Jing, primary, Ullrich, Stephen E., primary, Wistuba, Ignacio I., primary, Heymach, John V., primary, Qin, F. Xiao-Feng, primary, and Gibbons, Don L., primary

Published
2023
Full Text
View/download PDF

20. Data from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

22. Supplemental Figures 1-10 from Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer

Author

Mustachio, Lisa Maria, primary, Lu, Yun, primary, Tafe, Laura J., primary, Memoli, Vincent, primary, Rodriguez-Canales, Jaime, primary, Mino, Barbara, primary, Villalobos, Pamela Andrea, primary, Wistuba, Ignacio, primary, Katayama, Hiroyuki, primary, Hanash, Samir M., primary, Roszik, Jason, primary, Kawakami, Masanori, primary, Cho, Kwang-jin, primary, Hancock, John F., primary, Chinyengetere, Fadzai, primary, Hu, Shanhu, primary, Liu, Xi, primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Text and Legends from Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer

Author

Mustachio, Lisa Maria, primary, Lu, Yun, primary, Tafe, Laura J., primary, Memoli, Vincent, primary, Rodriguez-Canales, Jaime, primary, Mino, Barbara, primary, Villalobos, Pamela Andrea, primary, Wistuba, Ignacio, primary, Katayama, Hiroyuki, primary, Hanash, Samir M., primary, Roszik, Jason, primary, Kawakami, Masanori, primary, Cho, Kwang-jin, primary, Hancock, John F., primary, Chinyengetere, Fadzai, primary, Hu, Shanhu, primary, Liu, Xi, primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

24. Video-Supplementary Fig. 2a from Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2

Author

Danilov, Alexey V., primary, Hu, Shanhu, primary, Orr, Bernardo, primary, Godek, Kristina, primary, Mustachio, Lisa Maria, primary, Sekula, David, primary, Liu, Xi, primary, Kawakami, Masanori, primary, Johnson, Faye M., primary, Compton, Duane A., primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 1 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure S1 from Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models

Author

Dragnev, Konstantin H., primary, Ma, Tian, primary, Cyrus, Jobin, primary, Galimberti, Fabrizio, primary, Memoli, Vincent, primary, Busch, Alexander M., primary, Tsongalis, Gregory J., primary, Seltzer, Marc, primary, Johnstone, David, primary, Erkmen, Cherie P., primary, Nugent, William, primary, Rigas, James R., primary, Liu, Xi, primary, Freemantle, Sarah J., primary, Kurie, Jonathan M., primary, Waxman, Samuel, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Methods; Figures S1 - S22; Tables S2, S6, S9 - S12 from CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Author

Chen, Limo, primary, Diao, Lixia, primary, Yang, Yongbin, primary, Yi, Xiaohui, primary, Rodriguez, B. Leticia, primary, Li, Yanli, primary, Villalobos, Pamela A., primary, Cascone, Tina, primary, Liu, Xi, primary, Tan, Lin, primary, Lorenzi, Philip L., primary, Huang, Anfei, primary, Zhao, Qiang, primary, Peng, Di, primary, Fradette, Jared J., primary, Peng, David H., primary, Ungewiss, Christin, primary, Roybal, Jonathon, primary, Tong, Pan, primary, Oba, Junna, primary, Skoulidis, Ferdinandos, primary, Peng, Weiyi, primary, Carter, Brett W., primary, Gay, Carl M., primary, Fan, Youhong, primary, Class, Caleb A., primary, Zhu, Jingfen, primary, Rodriguez-Canales, Jaime, primary, Kawakami, Masanori, primary, Byers, Lauren Averett, primary, Woodman, Scott E., primary, Papadimitrakopoulou, Vassiliki A., primary, Dmitrovsky, Ethan, primary, Wang, Jing, primary, Ullrich, Stephen E., primary, Wistuba, Ignacio I., primary, Heymach, John V., primary, Qin, F. Xiao-Feng, primary, and Gibbons, Don L., primary

Published
2023
Full Text
View/download PDF

28. Data from A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers

Author

Kawakami, Masanori, primary, Mustachio, Lisa Maria, primary, Chen, Yulong, primary, Chen, Zibo, primary, Liu, Xiuxia, primary, Wei, Cheng-Hsin, primary, Roszik, Jason, primary, Kittai, Adam S., primary, Danilov, Alexey V., primary, Zhang, Xiaoshan, primary, Fang, Bingliang, primary, Wang, Jing, primary, Heymach, John V., primary, Tyutyunyk-Massey, Liliya, primary, Freemantle, Sarah J., primary, Kurie, Jonathan M., primary, Liu, Xi, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 5 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 2 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Fig. 2. from Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2

Author

Danilov, Alexey V., primary, Hu, Shanhu, primary, Orr, Bernardo, primary, Godek, Kristina, primary, Mustachio, Lisa Maria, primary, Sekula, David, primary, Liu, Xi, primary, Kawakami, Masanori, primary, Johnson, Faye M., primary, Compton, Duane A., primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

32. Data from Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy

Author

Zheng, Lin, primary, Chen, Zibo, primary, Kawakami, Masanori, primary, Chen, Yulong, primary, Roszik, Jason, primary, Mustachio, Lisa Maria, primary, Kurie, Jonathan M., primary, Villalobos, Pamela, primary, Lu, Wei, primary, Behrens, Carmen, primary, Mino, Barbara, primary, Solis, Luisa M., primary, Silvester, Jennifer, primary, Thu, Kelsie L., primary, Cescon, David W, primary, Rodriguez-Canales, Jaime, primary, Wistuba, Ignacio I., primary, Mak, Tak W., primary, Liu, Xi, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 1 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

34. Data from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure 4 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

36. Data from The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth

Author

Liu, Xi, primary, Lu, Yun, primary, Chen, Zibo, primary, Liu, Xiuxia, primary, Hu, Weiguo, primary, Zheng, Lin, primary, Chen, Yulong, primary, Kurie, Jonathan M., primary, Shi, Mi, primary, Mustachio, Lisa Maria, primary, Adresson, Thorkell, primary, Fox, Stephen, primary, Roszik, Jason, primary, Kawakami, Masanori, primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure Legend from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

38. Data from Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer

Author

Mustachio, Lisa Maria, primary, Lu, Yun, primary, Tafe, Laura J., primary, Memoli, Vincent, primary, Rodriguez-Canales, Jaime, primary, Mino, Barbara, primary, Villalobos, Pamela Andrea, primary, Wistuba, Ignacio, primary, Katayama, Hiroyuki, primary, Hanash, Samir M., primary, Roszik, Jason, primary, Kawakami, Masanori, primary, Cho, Kwang-jin, primary, Hancock, John F., primary, Chinyengetere, Fadzai, primary, Hu, Shanhu, primary, Liu, Xi, primary, Freemantle, Sarah J., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figure 6 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure 7 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

42. Figures S1-S6 from Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy

Author

Zheng, Lin, primary, Chen, Zibo, primary, Kawakami, Masanori, primary, Chen, Yulong, primary, Roszik, Jason, primary, Mustachio, Lisa Maria, primary, Kurie, Jonathan M., primary, Villalobos, Pamela, primary, Lu, Wei, primary, Behrens, Carmen, primary, Mino, Barbara, primary, Solis, Luisa M., primary, Silvester, Jennifer, primary, Thu, Kelsie L., primary, Cescon, David W, primary, Rodriguez-Canales, Jaime, primary, Wistuba, Ignacio I., primary, Mak, Tak W., primary, Liu, Xi, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 3 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

44. Supplementary figures from A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers

Author

Kawakami, Masanori, primary, Mustachio, Lisa Maria, primary, Chen, Yulong, primary, Chen, Zibo, primary, Liu, Xiuxia, primary, Wei, Cheng-Hsin, primary, Roszik, Jason, primary, Kittai, Adam S., primary, Danilov, Alexey V., primary, Zhang, Xiaoshan, primary, Fang, Bingliang, primary, Wang, Jing, primary, Heymach, John V., primary, Tyutyunyk-Massey, Liliya, primary, Freemantle, Sarah J., primary, Kurie, Jonathan M., primary, Liu, Xi, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure Legend from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Figure 3 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figure 2 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

50. FIELD REPORT: GETTING NEW FACULTY INTO THE FOLD-FAST

Author

Middleton, Lavinia P., Thompson, Lourdes, Starr-High, Evelyn, Travis, Elizabeth, Kurtin, Danna, Rodriguez, Alma, and Dmitrovsky, Ethan

Subjects
Industry hiring, Employee orientation -- Analysis, Medical personnel -- Recruiting
Abstract

Onboarding delays riot only cost institutions time and money, they also affect the morale of job candidates. To address concerns regarding physician engagement, alignment and productivity, a team at one institution set out to reduce the time to onboard clinical faculty by 25 percent. The current onboarding process was mapped, owners of each step of the process were identified, and the emerging connectivity of data systems explored. Learn how the team achieved its goal--and identified additional issues to address., ONBOARDING CLINICAL FACULTY CAN BE costly, time consuming and disjointed, resulting in dissatisfaction with the process and unintended delays in patient care and reimbursement. (1) Studies have shown an applicant's [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results